Katya Stefanova
Overview
Explore the profile of Katya Stefanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stefanova K, Delcheva G, Stankova T
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684440
Rheumatoid arthritis (RA) is an inflammatory autoimmune disease with articular and systemic manifestations, and one of the most common is anemia. This study aims to investigate whether the levels of...
2.
Delcheva G, Stefanova K, Stankova T
Diseases
. 2024 Sep;
12(9).
PMID: 39329864
Abnormalities in lipid homeostasis have been associated with many human diseases, and the interrelation between lipotoxicity and cellular dysfunction has received significant attention in the past two decades. Ceramides (Cers)...
3.
Delcheva G, Stankova T, Stefanova K, Bivolarska A
Cent Eur J Public Health
. 2023 Jul;
31(2):115-119.
PMID: 37451244
Objectives: Roma population is one of the major ethnic groups in the Central and Eastern Europe, having high rates of chronic diseases and associated risk factors related to their poor...
4.
Selimov P, Karalilova R, Damjanovska L, Delcheva G, Stankova T, Stefanova K, et al.
Folia Med (Plovdiv)
. 2023 Mar;
65(1):53-59.
PMID: 36855974
Introduction: Rheumatoid arthritis (RA) is the most common inflammatory joint disease. Various proinflammatory cytokines are involved in the pathogenesis of this chronic disorder. It is characterized by the presence of...
5.
Kraev K, Geneva-Popova M, Popova V, Popova S, Maneva A, Batalov A, et al.
Folia Med (Plovdiv)
. 2020 Jul;
62(2):282-289.
PMID: 32666748
Introduction: TNF-α blocker therapy is part of the treatment with biologics used in the management of inflammatory joint diseases. In recent years, drug-induced neutralizing antibodies have been shown to have...